Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
study@ JT and Co. seem to have now 'taken of the gloves' realizing that they are 'in for a battle' for the US market.
-----------------------------
I'm not usually a patient person - and talking 2023 'before a ruling' in an infringement case - just kills me - and it seem WS - looking at SP - feels much the same way.
Remember JL said 'several times' before he left the board - 'That he couldn't handle this Law nonsens' - and I do understand that all to well.
-----------------------------
As I said in input lately 'The Thrill is Gone' - for this stock at the moment (and very much so) - Just yesterday a Canadian cannabis Stock (low value - very unsecure) SNLD - had a Volume of 'hold on to your hat and glasses' - 2 billion shares traded.
Today AMRN even once more 'with Super News' - Amarin is finally 'fighting back' the volume is right now 5.5 mill (wont even reach normal average).
We just have to realize that 'this Stock is not hot 'at all' right now. There is very little interest outside of 'the ever Longs (like me) that for now has lost a fortune on this investment - like so many others here.
-------------------------------
Pdude has done a lot to 'gain optimisme' regarding the Covid trial announcement Dec. 12 - and respect for that' - but the experience with moves of AMRN SP since the Shock Marts Nevada ruling - Says' - that it seem almost impossible 'to regain' interest for AMRN - after gate opened for generics.
Already again today I saw mentioned here possible settlement with Hikma - even that wont solve anything stopping any other generic that wants 'to move in'.
-------------------------------
Truth is' that it is today very hard to imagine this Stock ever moving past 20 again. Only thing that can do that now' IS NUMBERS - EARNINGS that rocks.
Company has to start Making Money - only thing that could 'in one move' move SP above 20 - would be restoring patents - and I do not think that many neither here' nor at Amarins have much faith in that ever happening.
---------------------------------
Personally I dont believe that Hikma will be scared away by this lawsuit - sad to say. I think they will just move ahead - and keep stealing prescription's from Amarin (the US drug system does that for them - they dont even have to do anything).
Amarin payes for DTC's and 800 reps - to make Vasepa known - and Hikma (and comming generics) prescriptions keeps rising (the hard and sad truth). And a trial in 900 days - I really dont think that will 'scare generics' - and especially not with incoming Administration in US.
We will have to see. Everyone want the best for Amarin. Naturally because we are Shareholders - but also for the sake of the hundred of millions of CDV patients of the world.
Maybe the solution to this 'very difficult (and completely unexpected situation) for Amarin management is to 'at the same time they go for the
infringement case - to at the same time 'take the battle to the market' going AG in US.
In the end that might be the only way for Amarin 'to gain themselves 'also' for the big marketing costs' - not just handeling everything' on a silver plate' - for the generic to enter the market for free.
Jasbg
Louie@ Think your right here:
From the Markman article you linked to:
Another significant consideration from the GSK v. Teva decision is that the Court found Teva liable for all of GSK’s lost profits, even though Teva was only one of at least eight generic drugs for Coreg® that had entered the market. Yet, Teva was the only generic that was sued by GSK. What that means is, Amarin can threaten to sue either Hikma or Dr. Reddy’s alone for all of its lost profits, even if there are other generics on the market, which might also include Teva or Apotex. Indeed, to the extent Teva has the opportunity to enter the market any time soon, then coincidentally, Amarin could choose to sue Teva alone.
ralp@ Great input - that has 2 things going for it:
1. It will make a lot of sense to most normal people.
2. It is 100% the truth.
-------------------------
At a time where 'the truth and honesty' seems in low supply in USA - hopefully - the majority of people will still be seeking the 'truth' in the end.
iwan@ SNDL (the one your obviously referring to) - truly show you point - to an extend of pure madness today - not at least looking at volume.
Some Broker's made fortunes on this 'in fact' very low value stock today.
There a lot of 'Lemming effect' in the stock market these days (have in fact always been there - but with the easy access to trading - it's growing all the time):
https://finance.yahoo.com/quote/SNDL?p=SNDL&.tsrc=fin-srch
I have put the link to this guy (talking Lemming effect) a couple of times here earlier. If you haven't seen it - it's worth the time.
He's part of a famous Podcast program in Denmark - where 4 well know traders gets 250.000 DK start of every year - and compete who can do best in the markets. This year TH in June hit +80 mill DK (later lost 30 - he's about 65 today). But as he says: "If you trade like 'everyone else' - you will end up loosing' like all the rest :)
louie@ That is simply a brilliant idea :)
I actually think Amarin needs to move fast' before some one steals it !
Wha@ Pdude rally - LOL - something like this would be good (look at the insane volume):
https://finance.yahoo.com/quote/SNDL?p=SNDL&.tsrc=fin-srch
Obviously a lot of Canadians are smoking Pot - and certainly today if the own this stock !
louie@ Young' is a problem - Breathing' there's always hope :)
louie@ Here is something to be 'prepared' when the 'gold starts raining' :)
https://www.google.com/search?q=best+vine+in+USA&tbm=isch&ved=2ahUKEwj8id6vtqrtAhWaNuwKHcEdDo8Q2-cCegQIABAA&oq=best+vine+in+USA&gs_lcp=CgNpbWcQA1C5K1i5K2DLMGgAcAB4AIABXogBXpIBATGYAQCgAQGqAQtnd3Mtd2l6LWltZ8ABAQ&sclient=img&ei=afrEX7yxC5rtsAfBu7j4CA&bih=695&biw=1332
Jasbg
Pharma@ There were every reason to be angry and bitter - over Nevada ruling - because it was based on deliberate fraud from generics.
I still would very much want patents restored (generic stopped). But with political development in USA - that does seem 'a thin hope' for sure.
-------------------
So for now we will cross fingers and toes for your brave predictions of the future for Vascepa and Amarin :)
ATB
Jasbg
Pharma@ That is Optimism for You :)
Losing could turn out to be a GOOD thing.
HK@ Funny how you can feel - that you have known people 'half you life' reading post's on an board like iHub AMRN.
-----------------------------
Just a couple of personal remarks' - from experience in life (even we come from very different backgrounds).
Your answers to rather trivial questions here - to other posters personal questions (like from me about wife) - is what to me indicate 'here we have a 'real caring medical genius' - who's nature it is 'to help others whenever possible'.
This is what makes me 100% sure that you will be able - to Move also BIG Decisions at Amarin's - with the absolute unique Knowledge in Vascepa background and trials - that everyone in this board knows you hold.
-------------------------------
Once again - Best of Luck - and Amarin 'will call you In' - They have to :)
Jasbg
Ziploc@ Just looking at your post (not knowing every detail in this matter) I completely agree with you.
Legal matters take 'to long' in this case to - 'Wait and See' !
-------------
Amarin has to go AG in US (take the battle to the market') - but at the same time keep the Brand - as you argue. That is the only answer to current development.
And it has to happen 'ASAP' - to take the Wind out of Generic Sails - for now Hikma.
https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/fda-list-authorized-generic-drugs
FDA Rules for 'Authorized Generic' (AG) updated recently:
https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/fda-list-authorized-generic-drugs
sleven@ This question in not for me - I'm an absolute Lay Person in Law :)
Hope Marjac or Eight might be around - they will be able to answer your question !
HK@ You just made my day and Christmas - Thanks :)
Best of luck !
Jasbg
To the AMRN iHub Board - here is my Thanks Giving Wish - for Amarin and all of us Longs who 'many for now' have lost fortunes - after Marts 2020 - loss in Nevada trial.
-----------------------
And have to stress that this is wishful thinking from following this board for a couple of years rather closely - and I hope that the 2 people I mention will not be offended by my thoughts/proposals.
-----------------------
I think that we are many here that feel - that Amarin (after Hikma entering market with GV 3 weeks ago) is at a critical point - in where to go from here.
Two people from this board - would in my opinion be 'The right medicine to give Amarin a chance - to 'shake up' things for the Company - to chose the right direction for the future - for shareholders - and for CDV patients WW.
One of them Hindu Kush - (an absolute genius in the Scientific and medical field of bio world) I have already contacted him here directly - on a open Job (to me) made for him at Amarin's.
--------------------------------
The other poster I would love to 'put new thoughts and plans' into the mind of Amarin BOD is poster Will Lar - who has a lot of experience in doing business in Europe.
Will has the right attitude against 'Amarin needing a broader pipeline' - need to OWN production facilities (independence) etc. From the forum here - Will is very well argued - my feeling - I would love this guy being part if Amarin team for planning the future.
------------------------------
Again have to stress - these is my personal ideas of - what could Move Things at Amarin's.
Haven't confronted either posters with the Ideas directly - but hope that they will not be offended - by me suggesting them to be part of my thoughts - of Saving Amarin - for the CDV patients of the World :)
Jasbg
BB@ Problem here is 'time'. Lawsuit's takes a lot of 'time' - and in the meantime Generics - could easily have stolen a very big part of Vascepa market in USA (a lot more than 10% - more like eg. 50% before any court case).
-------------------
Generics on Infringement: "Not our fault that States and Insurances 'demands' Generics if available" - "We are just a company that sell's Drugs - and tries to fill demands" - Label ? "What label is that you are talking about" ?
-------------------
This fight has entered a New Dimension.
Amarin shall pursue the small chance of taking patent case to Supreme Court !
But at the same time 'plan on taking the fight 'to the Market in US'- and 'that we can already' in 3 weeks see' means Going AG - 'you have to be generic in US today - as soon 'other generics' have entered the market - to stand a chance. How long before Dr. Reddy - Teva - Apotex enters also ?
After 3 weeks it is already obvious (and Hikma and Reddy knew that from years of experience - with lots and lofts of drugs) - as soon as generic available - this will very fast overtake Brand.
Maybe the biggest of BP would be able to Protect Brand value to some extend - as it looks right now for Amarin in US - there is nothing to stop Generics (they will find the raw materials they need - these are big and powerful companies - with influence and means).
Jasbg
rose@ I cant speak for the whole of Europe - but your right that the courts - are not in anyway as 'politically engaged' as in USA.
Most people se the courts as 'what they should be' - non political. Mostly concerned around criminals cases - and disputes generally between companies internally and/or private citizen's.
Jasbg
tuca@ Thanks again. Not nice reading - but the truth is the truth.
-------------------
All the way back to where Amarin downfall began - I newer think that Amarin fully understood what they were up against in the patent case.
The Lawyers at Hilma (591 drugs) - and Dr. Reddy (190 drugs) do these patent cases all the time - they Are Specialists - in every bit of Litigation - and Using whatever means needed to win.
Surely the fraud used to win over Amarin - will not be the first time these Lawyers have 'bend the truth' to win - nor will it be the last.
--------------------
As it looks now JT - it do look that the expensive DTC's and reps are only helping Hikma - who gains as Brand Amarin falls back. This development cant go on for long - before some change in policy has to happen at Amarin.
HK@ Don't know where you live in US.
But if you will be aloud by your family - 'apply for the job HK' - and go save the Company for us' (and yourself).
You're the man who can DO IT :)
Jasbg
PS. But do not loose your family over it. If family 'says no' rest of us have to live with the loss - and you shouldn't loose sleep over it :)
FFS@ Your welcome. I know that Tom use - mostly:
https://www.etxcapital.com/en/us - so this must be good for Day Trading - have not used it myself.
-------------------------------
I'm one of the loosing traders. In my case Amarin is the cause of my biggest loss till now - hope It will Change at some point :)
FFS@ The ever returning TA discussion - never ends :)
-----------------------
I feel you are a serious guy about investment and trading - and this being Holliday in USA - I will send you a link - that touches TA - and a number of other know tools for Trading in the market:
Have to stress that this Guy is DayTrader - and DayTrader BIGTIME.
Being part of a locally in Denmark Famous Podcast (4 trading specialists competing every year who can make it the best (biggest profits) out of starting with 250 K danish KR.
In 2020 this guy managed to make the 0.250 million - into 80 million in June. Later lost 30 mill. now I think he is around 65 mill. Still absolutely vild :)
Listen to his philosophy regarding trading - gears up to 150 - not for 'small boys' :)
FFS@ iHub have problems handling the picture/chart you put in.
---------------------
Exiting analogy - about 'the edges of the river' - and investment. I will remember that - Thanks :)
Jasbg
HK@ Just to make sure you see this.
To me (not being a specialist in these matters) - it seems like this Job - 'is made for you' - and with all the demands i suppose salary will be good (maybe ½ in AMRN shares) :)
It would make me 'hold on to every share' - knowing you onboard at Amarins.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159738593
Happy Thanks Giving :)
Jasbg
HK@ I think Amarin made a Job 'especially for You' :)
https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=21628469-e451-428a-9cbf-7efe4cef17a8
The link do not connect directly - you have to go to link:
'Publications Process Lead'
----------------------------------
Jasbg
HK@ Said it before that Amarin should Hire You - to go 'Get' these generic thieves (one way or another) :)
Raf@ Some more specific information about Lisa Jiao - and relation to Amarin:
https://www.fiercepharma.com/special-report/lisa-jiao-amarin-2020-s-fiercest-women-life-sciences
Pharm@ Very impressive work. I especially like that you made it visual wherever possible.
JT/Amarin are so lucky to have people like you on their side - and ought to send you a nice Christmas present.
Jasbg
I will answer my own question from yesterday - about 'Legal process/progress'?
Nothing new on Supreme Court (I was stunned that it is only 20 days since En Banc Denial - feels like another life):
From the document linked below:
On November 4, 2020, Amarin’s rehearing and en banc petitions were denied, the court’s order is
available here. Amarin plans to file a writ of certiorari within 90 days of such denial to ask the United
States Supreme Court to hear Amarin’s appeal. Amarin intends to vigorously pursue this matter but
cannot predict the outcome.
Tal@ Thanks - good that someone knows how to read the numbers correct :)
mrmain@ Simple answer - Amarin stil does not make money!
Net income 2020= - 26M - and with the Generic now in Play - what will the future bring in US ?
-------------------
What i dont quite understand in MarketScreener is why Net Cash position is only 146 M (JT always talk about 600 M - in cash) hopefully it is an error:
https://www.marketscreener.com/quote/stock/AMARIN-CORPORATION-PLC-1658813/
https://www.marketscreener.com/quote/stock/AMARIN-CORPORATION-PLC-1658813/company/
rose@ Hope your 'not right' - even though you probably are'.
---------------------------
After patent loss - 'The Thrill is Gone' - -
yud@ No One is talking 'official anything' - regarding this simple question - that I noticed.
There is a lot of people on this board that take Vascepa - which makes A Poster - have the thought to ask 'have many Vascepa users - have had Covid amongst posters here - nothing more to it.
Of course it could be seen as an indication' - that this would be interesting to look into - in a Real Study.
yod@ Why is it flawed to ask people if they had Covid ?
It is a completely legitimate and logic question. And especially in this forum where many are taking the drug.
cmm@ Very 'thought through input' - trying to help AMRN. But my feeling - about US market - after two decades of Investing - is not good right now - have to admit.
-----------------------
BB a couple of days talking about HIKMA 'forced' to settle' - 2 days later we hear from Tucaman - that this completely new Generic in - 'TWO WEEKS' - stole +5% form Amarins prescriptions. And what would settling with HIKMA solve anyway.
To be honest I think that HIKMA is more worried about Reddy - Teva and Apotex - in the US marked - than Amarin.
-----------
In the last two podcasts with JT I didn't hear one word about the legal process - of restoring lost Patents.
Not Good - as I see development right now 'A win in Court' - will be the only way for Amarin to Keep the US marked. As of today Generic's will Eats this Drug's potential - as they have done so very many times before.
This all in the New Political norm of USA - (all developers of DRUGS are Bandits - which it is legal and fair to Steal/Copy - for the good of the people ).
Relevant news for US Patient using medical Drugs.
Is this good for investors in Vascepa (AMRN). The way 2020 has been so far - probably not ?
Following an earlier than expected favorable court ruling